Acuren Insider Filing Shows Large Share Conversion After NV5 Deal
Rhea-AI Filing Summary
Form 4 highlights: Acuren Corp. (TIC) director Dickerson Wright reported the conversion and acquisition of Acuren common shares on 08/04/2025 following the closing of the NV5 Global merger. In exchange for 13,328 NV5 shares and 157,716 vested NV5 RSAs, Mr. Wright received the merger consideration of 1.1523 TIC shares plus $10 cash per NV5 share.
Indirect ownership: Nine family trusts now hold between 480.7k-2.30m shares each, bringing Wright’s indirect beneficial stake to roughly 8.0 million TIC shares. Wright disclaims beneficial ownership beyond his pecuniary interest but exercises voting and investment power as trustee.
Direct ownership: 9,524 restricted stock units were granted on 08/04/2025; they vest one year later and will settle in an equal number of TIC shares. No shares were disposed of.
Post-transaction, Wright’s economic exposure to Acuren materially increases, aligning his interests with shareholders as the combined entity begins trading.
Positive
- ~8 million TIC shares moved under Wright-controlled trusts, increasing insider alignment with shareholders.
- No shares sold; all activity stems from merger conversion, signalling long-term holding intent.
Negative
- None.
Insights
TL;DR: Wright’s family trusts gained ~8 m TIC shares via merger conversion; alignment positive but routine for closing.
The filing documents share issuance tied to the NV5–Acuren merger, not an open-market purchase. Although the absolute number (≈8 m shares plus 9,524 RSUs) seems large, it reflects automatic conversion, so cash outlay is zero and market-signal value is modest. Still, Wright’s enlarged stake strengthens long-term incentive alignment. No dispositions, option exercises, or sales limits downside concern. Impact on float is already embedded in merger terms; therefore, the disclosure is governance-neutral rather than market-moving.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 9,524 | $0.00 | -- |
| Grant/Award | Common Stock | 2,301,994 | $0.00 | -- |
| Grant/Award | Common Stock | 683,701 | $0.00 | -- |
| Grant/Award | Common Stock | 944,148 | $0.00 | -- |
| Grant/Award | Common Stock | 480,702 | $0.00 | -- |
| Grant/Award | Common Stock | 683,701 | $0.00 | -- |
| Grant/Award | Common Stock | 741,150 | $0.00 | -- |
| Grant/Award | Common Stock | 944,148 | $0.00 | -- |
| Grant/Award | Common Stock | 480,702 | $0.00 | -- |
| Grant/Award | Common Stock | 741,150 | $0.00 | -- |
Footnotes (1)
- On August 4, 2025, as a result of the mergers contemplated by that certain Agreement and Plan of Merger, dated as of May 14, 2025, by and among the Issuer, NV5 Global, Inc. ("NV5"), Ryder Merger Sub I and Ryder Merger Sub II (the "Merger Agreement"), 13,328 shares of common stock of NV5 and 157,716 restricted stock awards of NV5 (which were vested in full in accordance with their terms immediately prior to the effective time of the mergers and converted into the right to receive the Merger Consideration, less applicable tax withholdings)were converted into the right to receive 1.1523 shares of the Issuer's common stock ("Common Stock") per share, and $10.00 in cash per share, without interest (collectively, the "Merger Consideration"). Pursuant to the Merger Agreement, any outstanding restricted stock award of NV5 held by the Reporting Person automatically vested in full in accordance with its terms immediately prior to the effective time of the mergers. Dickerson Wright and his wife, Katherine Wright, are trustees. As a trustee, the Reporting Person may be deemed to exercise voting and investment power over the shares held by each trust. Mr. Wright disclaims beneficial ownership of these securities except to the extent of this pecuniary interest therein. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. These restricted stock units vest on August 4, 2026 (the one-year anniversary of the grant date).
